MTA3 and gastroesophageal junction adenocarcinoma: Our results indicate that the MTA3-regulated EMT pathway is altered to favor EMT in GEJ adenocarcinoma and that MTA3 expression is an independent prognostic factor in patients with GEJ adenocarcinoma.